A review containing more methamphetamine-related deficits than amphetamine-related deficits does not necessarily show that methamphetamine produces a larger effect under equivalent conditions. The comparison depends on which animals, exposure schedules and tests entered the evidence base. A 2026 systematic review makes that problem particularly visible: its 37 included publications were divided into 27 methamphetamine studies and 10 amphetamine studies, with substantial differences in experimental methods.
What evidence did the review actually collect?
Poorvii and colleagues searched four databases on December 1, 2025, and included original English-language rodent studies published between 1971 and 2025. The review required an abstinence period and relevant behavioral testing. It was a synthesis of animal experiments, not a new human withdrawal trial, a clinical prognosis study or a pooled estimate of individual impairment.
The number 37 counts publications. It does not count independent people, and it should not be quoted as though 37 experiments all used the same protocol. The article organized findings by tasks such as object recognition, object placement, water mazes, temporal-order memory and attentional learning. These tasks operationalize different abilities; a deficit on one cannot silently become a deficit on all of them.
Why is an apparent drug difference difficult to interpret?
Methamphetamine studies commonly used intraperitoneal administration, but the collection also included intravenous self-administration, subcutaneous injection and oral exposure. Amphetamine protocols likewise varied in route, repetition and escalation. An injected dose expressed in mg/kg, an infusion dose, and a drug concentration in drinking water are different exposure descriptions.
The reviewers considered methamphetamine findings more consistent, while acknowledging broader dosing ranges, higher maximum doses and greater use of extended-access procedures in that literature. Those differences provide competing explanations for the pattern. A fair drug comparison would need appropriately matched exposure conditions, animal characteristics, withdrawal intervals and outcomes. Counting positive findings across unequal literatures does not supply that comparison.
Which null findings should remain visible?
The review’s own tables contain important exceptions. Table 5 describes the North study as finding impaired spatial recognition at 7, 14 and 21 days after methamphetamine exposure, while object recognition was unaffected. Table 6 describes an amphetamine study by Russig and colleagues as showing no impairment of spatial acquisition or retention, together with enhanced reversal learning. These are findings reported through the review; they are not presented here as independently reanalyzed primary experiments.
The distinctions matter. Remembering where an object was located differs from recognizing the object. Learning an initial platform location differs from changing to a new one. A result can therefore be positive for one endpoint and null or improved for another without inconsistency. An absence of statistical significance also does not establish exact equivalence.
How strong was the review’s assessment of bias?
The authors used the SYRCLE animal-study risk-of-bias framework. Many ratings were unclear because allocation concealment, blinding and housing procedures were insufficiently reported. An unclear rating does not prove that investigators used a poor method; it means the published information does not let a reader establish the safeguard.
A separate limitation deserves particular attention: the review states that only statistically significant results were discussed, despite its tables retaining a number of null findings. Emphasizing significance can make a heterogeneous literature sound more uniformly adverse than the complete endpoint record supports. The reader should examine the tables alongside the narrative and resist converting the discussion into a prevalence estimate for cognitive injury.
Can these findings establish a human recovery timetable?
No. Animals were tested after specified withdrawal intervals, but those intervals cannot be converted directly into a person’s number of days to recovery. Routes, cumulative intake, species, strain, sex and task demands all influence the comparison. A controlled animal experiment may support an exposure effect within its own model while remaining insufficient to explain a particular person’s symptoms.
For a case assessment, the useful contribution is methodological: identify the exact claimed ability, distinguish active exposure from withdrawal, preserve null outcomes, and ask whether the cited regimen actually resembles the question being addressed. Neither a positive methamphetamine test nor this review alone establishes current impairment or the cause of an individual’s cognitive difficulty.
Scientific source
Poorvii R, Mohamed IN, Yahaya MF, et al. Cognitive effects of methamphetamine and amphetamine withdrawal in rodents: a systematic review. Frontiers in Psychology. 2026;17:1729722. doi:10.3389/fpsyg.2026.1729722. Original commentary on the supplied review; the historical experiments discussed above are identified through that review.
Leave a Reply